Literature DB >> 23268106

Antioxidant properties of Neu2000 on mitochondrial free radicals and oxidative damage.

Nishant P Visavadiya1, Melanie L McEwen, Jignesh D Pandya, Patrick G Sullivan, Byoung Joo Gwag, Joe E Springer.   

Abstract

Neu2000 [2-hydroxy-5-(2,3,5,6-tetrafluoro-4 trifluoromethylbenzylamino) benzoic acid] is a dual-acting neuroprotective agent that functions both as a noncompetitive N-methyl-d-aspartate (NMDA) receptor antagonist and a free radical scavenger. In the present study, we investigated the scavenging activity of Neu2000 on various classes of reactive oxygen species and reactive nitrogen species (ROS/RNS) as well as its efficacy for reducing free radicals and oxidative stress/damage induced in spinal cord mitochondrial preparations. Neu2000 exerted scavenging activity against superoxide, nitric oxide, and hydroxyl radicals, and efficiently scavenged peroxynitrite. In the mitochondrial studies, Neu2000 markedly inhibited ROS/RNS and hydrogen peroxide levels following antimycin treatment. In addition, Neu2000 effectively scavenged hydroxyl radicals generated by iron(III)-ascorbate, reduced protein carbonyl formation mediated by hydroxyl radicals and peroxynitrite, and prevented glutathione oxidation caused by tert-butyl hydroperoxide in isolated mitochondria. Interestingly, incubation of isolated mitochondria with Neu2000 followed by centrifugation and removal of the supernatant also resulted in a concentration-dependent decrease in lipid peroxidation. This observation suggests that Neu2000 enters mitochondria to target free radicals or indirectly affects mitochondrial function in a manner that promotes antioxidant activity. The results of the present study demonstrate that Neu2000 possesses potent in vitro antioxidant activity due, most likely, to its active phenoxy group.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23268106     DOI: 10.1016/j.tiv.2012.12.011

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  10 in total

1.  In vitro studies to assess the antioxidative, radical scavenging and arginase inhibitory potentials of extracts from Artocarpus altilis, Ficus exasperate and Kigelia africana.

Authors:  Olubukola Oyebimpe Akanni; Solomon Eduviere Owumi; Oluwatosin Adekunle Adaramoye
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

Review 2.  Mitochondrial-Based Therapeutics for the Treatment of Spinal Cord Injury: Mitochondrial Biogenesis as a Potential Pharmacological Target.

Authors:  Natalie E Scholpa; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2017-09-21       Impact factor: 4.030

3.  Neuroprotective Effect and Mechanism of Action of Tetramethylpyrazine Nitrone for Ischemic Stroke Therapy.

Authors:  Gaoxiao Zhang; Tao Zhang; Liangmiao Wu; Xinhua Zhou; Jianbo Gu; Cuimei Li; Wei Liu; Cheng Long; Xifei Yang; Luchen Shan; Lipeng Xu; Yuqiang Wang; Yewei Sun; Zaijun Zhang
Journal:  Neuromolecular Med       Date:  2018-02-06       Impact factor: 3.843

4.  Mitochondrial dynamics and quality control are altered in a hepatic cell culture model of cancer cachexia.

Authors:  Nishant P Visavadiya; Gabriel S Pena; Andy V Khamoui
Journal:  Mol Cell Biochem       Date:  2020-08-14       Impact factor: 3.396

5.  Concentration dependent effect of calcium on brain mitochondrial bioenergetics and oxidative stress parameters.

Authors:  Jignesh D Pandya; Vidya N Nukala; Patrick G Sullivan
Journal:  Front Neuroenergetics       Date:  2013-12-18

Review 6.  Mechanism Underlying Acupuncture Therapy in Spinal Cord Injury: A Narrative Overview of Preclinical Studies.

Authors:  Kunpeng Jiang; Yulin Sun; Xinle Chen
Journal:  Front Pharmacol       Date:  2022-04-07       Impact factor: 5.988

7.  Rationale and methods of the Antioxidant and NMDA receptor blocker Weans Anoxic brain damage of KorEa OHCA patients (AWAKE) trial.

Authors:  Jin-Ho Choi; Byeong Jo Chun; Seok Ran Yeom; Sung Phil Chung; Young Hwan Lee; Yun-Hee Kim; Ji Sung Lee; Jin Hwan Lee; Hwan Goo Lee; Jing Yu Jin; Chun San An; Byoung Joo Gwag
Journal:  Trials       Date:  2022-07-23       Impact factor: 2.728

8.  Cellular and subcellular oxidative stress parameters following severe spinal cord injury.

Authors:  Nishant P Visavadiya; Samir P Patel; Jenna L VanRooyen; Patrick G Sullivan; Alexander G Rabchevsky
Journal:  Redox Biol       Date:  2015-12-30       Impact factor: 11.799

9.  Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial.

Authors:  Ji Man Hong; Mun Hee Choi; Sung-Il Sohn; Yang-Ha Hwang; Seong Hwan Ahn; Yeong-Bae Lee; Dong-Ick Shin; Ángel Chamorro; Dennis W Choi
Journal:  Trials       Date:  2018-07-13       Impact factor: 2.279

Review 10.  Excitotoxicity: Still Hammering the Ischemic Brain in 2020.

Authors:  Dennis W Choi
Journal:  Front Neurosci       Date:  2020-10-26       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.